Manager file · vg · VIKING GLOBAL INVESTORS LP
Viking Global Investors
EDGAR CIK 1103804 ↗ · Waiting · typical filing lag 45 days
Reported portfolio value
$27.44B
first quarter on file
Positions
83
no prior quarter
Top 10 concentration
38.6%
largest position 5.6%
Position churn · Q3 2024
— added · — trimmed
new positions — · exits — of book
Holdings · Q3 2024 · 83
| Security | Weight | Δ wt | Price* | Shares | Δ shares | Value | Action | |
|---|---|---|---|---|---|---|---|---|
| 1 | USB US BANCORP DEL | 5.60% | — | $46 | 33.62M | new | $1.54B | New |
| 2 | ADBE ADOBE INC | 4.95% | — | $518 | 2.62M | new | $1.36B | New |
| 3 | AAPL APPLE INC | 4.13% | — | $233 | 4.86M | new | $1.13B | New |
| 4 | PM PHILIP MORRIS INTL INC | 4.01% | — | $121 | 9.05M | new | $1.10B | New |
| 5 | V VISA INC | 3.51% | — | $275 | 3.51M | new | $964M | New |
| 6 | — SPOTIFY TECHNOLOGY S A | 3.46% | — | $369 | 2.58M | new | $950M | New |
| 7 | FTV FORTIVE CORP | 3.39% | — | $79 | 11.80M | new | $931M | New |
| 8 | PGR PROGRESSIVE CORP | 3.22% | — | $254 | 3.49M | new | $885M | New |
| 9 | MSFT MICROSOFT CORP | 3.21% | — | $430 | 2.04M | new | $880M | New |
| 10 | APG API GROUP CORP | 3.09% | — | $33 | 25.71M | new | $849M | New |
| 11 | WDAY WORKDAY INC | 2.91% | — | $244 | 3.27M | new | $799M | New |
| 12 | BAC BANK AMERICA CORP | 2.89% | — | $40 | 19.96M | new | $792M | New |
| 13 | JPM JPMORGAN CHASE & CO. | 2.84% | — | $211 | 3.70M | new | $779M | New |
| 14 | AMZN AMAZON COM INC | 2.75% | — | $186 | 4.05M | new | $755M | New |
| 15 | BMRN BIOMARIN PHARMACEUTICAL INC | 2.50% | — | $70 | 9.75M | new | $686M | New |
| 16 | BBIO BRIDGEBIO PHARMA INC | 2.33% | — | $25 | 25.12M | new | $640M | New |
| 17 | — ROIVANT SCIENCES LTD | 2.28% | — | $12 | 54.10M | new | $624M | New |
| 18 | — FLUTTER ENTMT PLC | 2.20% | — | $237 | 2.55M | new | $604M | New |
| 19 | DASH DOORDASH INC | 1.87% | — | $143 | 3.60M | new | $514M | New |
| 20 | SHW SHERWIN WILLIAMS CO | 1.81% | — | $382 | 1.30M | new | $497M | New |
| 21 | TEAM ATLASSIAN CORPORATION | 1.72% | — | $159 | 2.97M | new | $472M | New |
| 22 | LVS LAS VEGAS SANDS CORP | 1.59% | — | $50 | 8.67M | new | $436M | New |
| 23 | ALL ALLSTATE CORP | 1.41% | — | $190 | 2.04M | new | $387M | New |
| 24 | MET METLIFE INC | 1.35% | — | $82 | 4.49M | new | $370M | New |
| 25 | CPT CAMDEN PPTY TR | 1.33% | — | $124 | 2.96M | new | $366M | New |
| 26 | — ROYALTY PHARMA PLC | 1.25% | — | $28 | 12.09M | new | $342M | New |
| 27 | MCD MCDONALDS CORP | 1.24% | — | $305 | 1.12M | new | $341M | New |
| 28 | CSX CSX CORP | 1.18% | — | $35 | 9.35M | new | $323M | New |
| 29 | HCA HCA HEALTHCARE INC | 1.03% | — | $406 | 698K | new | $284M | New |
| 30 | VRT VERTIV HOLDINGS CO | 1.02% | — | $99 | 2.81M | new | $280M | New |
| 31 | NVDA NVIDIA CORPORATION | 1.00% | — | $121 | 2.27M | new | $275M | New |
| 32 | GEV GE VERNOVA INC | 0.94% | — | $255 | 1.01M | new | $258M | New |
| 33 | TRU TRANSUNION | 0.92% | — | $105 | 2.40M | new | $251M | New |
| 34 | TMUS T-MOBILE US INC | 0.87% | — | $206 | 1.15M | new | $237M | New |
| 35 | KKR KKR & CO INC | 0.86% | — | $131 | 1.81M | new | $236M | New |
| 36 | ACHC ACADIA HEALTHCARE COMPANY IN | 0.86% | — | $63 | 3.70M | new | $235M | New |
| 37 | VST VISTRA CORP | 0.79% | — | $119 | 1.84M | new | $218M | New |
| 38 | GOOGL ALPHABET INC | 0.77% | — | $166 | 1.28M | new | $212M | New |
| 39 | ADSK AUTODESK INC | 0.77% | — | $275 | 762K | new | $210M | New |
| 40 | CBRE CBRE GROUP INC | 0.71% | — | $124 | 1.57M | new | $196M | New |
| 41 | — AON PLC | 0.71% | — | $346 | 563K | new | $195M | New |
| 42 | INTU INTUIT | 0.66% | — | $621 | 290K | new | $180M | New |
| 43 | SNPS SYNOPSYS INC | 0.65% | — | $506 | 352K | new | $178M | New |
| 44 | — CARNIVAL CORP | 0.64% | — | $18 | 9.56M | new | $177M | New |
| 45 | SBUX STARBUCKS CORP | 0.59% | — | $97 | 1.67M | new | $162M | New |
| 46 | FCX FREEPORT-MCMORAN INC | 0.57% | — | $50 | 3.14M | new | $157M | New |
| 47 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | 0.56% | — | $5 | 29.99M | new | $154M | New |
| 48 | SCHW SCHWAB CHARLES CORP | 0.55% | — | $65 | 2.34M | new | $152M | New |
| 49 | CRM SALESFORCE INC | 0.54% | — | $274 | 544K | new | $149M | New |
| 50 | NFLX NETFLIX INC | 0.53% | — | $709 | 205K | new | $145M | New |
| 51 | ZS ZSCALER INC | 0.53% | — | $171 | 848K | new | $145M | New |
| 52 | ITGR INTEGER HLDGS CORP | 0.53% | — | $130 | 1.11M | new | $144M | New |
| 53 | TEVAN TEVA PHARMACEUTICAL INDS LTD | 0.50% | — | $18 | 7.57M | new | $136M | New |
| 54 | LLY ELI LILLY & CO | 0.49% | — | $886 | 152K | new | $135M | New |
| 55 | — NEWAMSTERDAM PHARMA COMPANY | 0.49% | — | $17 | 8.02M | new | $133M | New |
| 56 | OSCR OSCAR HEALTH INC | 0.48% | — | $21 | 6.17M | new | $131M | New |
| 57 | CMCSA COMCAST CORP NEW | 0.47% | — | $42 | 3.09M | new | $129M | New |
| 58 | EQH EQUITABLE HLDGS INC | 0.47% | — | $42 | 3.05M | new | $128M | New |
| 59 | MMM 3M CO | 0.42% | — | $137 | 841K | new | $115M | New |
| 60 | AMP AMERIPRISE FINL INC | 0.42% | — | $470 | 243K | new | $114M | New |
| 61 | TSLA TESLA INC | 0.42% | — | $262 | 436K | new | $114M | New |
| 62 | LAB STANDARD BIOTOOLS INC | 0.41% | — | $2 | 58.65M | new | $113M | New |
| 63 | RCI ROGERS COMMUNICATIONS INC | 0.40% | — | $40 | 2.70M | new | $109M | New |
| 64 | RRX REGAL REXNORD CORPORATION | 0.38% | — | $166 | 630K | new | $105M | New |
| 65 | CSGP COSTAR GROUP INC | 0.35% | — | $75 | 1.26M | new | $95.14M | New |
| 66 | BSX BOSTON SCIENTIFIC CORP | 0.30% | — | $84 | 967K | new | $81.05M | New |
| 67 | — PHARVARIS N V | 0.25% | — | $19 | 3.65M | new | $67.66M | New |
| 68 | IMVT IMMUNOVANT INC | 0.24% | — | $29 | 2.32M | new | $66.17M | New |
| 69 | LBPH LONGBOARD PHARMACEUTICALS IN | 0.24% | — | $33 | 1.97M | new | $65.63M | New |
| 70 | LI LI AUTO INC | 0.19% | — | $26 | 2.08M | new | $53.23M | New |
| 71 | REGN REGENERON PHARMACEUTICALS | 0.19% | — | $1.05K | 50K | new | $52.43M | New |
| 72 | ZLAB ZAI LAB LTD | 0.17% | — | $24 | 1.95M | new | $47.07M | New |
| 73 | CVNA CARVANA CO | 0.17% | — | $174 | 269K | new | $46.85M | New |
| 74 | VKTX VIKING THERAPEUTICS INC | 0.17% | — | $63 | 722K | new | $45.71M | New |
| 75 | ORIC ORIC PHARMACEUTICALS INC | 0.15% | — | $10 | 4.00M | new | $41.00M | New |
| 76 | EWTX EDGEWISE THERAPEUTICS INC | 0.14% | — | $27 | 1.48M | new | $39.53M | New |
| 77 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 0.13% | — | $14 | 2.56M | new | $35.64M | New |
| 78 | DNA GINKGO BIOWORKS HOLDINGS INC | 0.11% | — | $8 | 3.58M | new | $29.15M | New |
| 79 | INBX INHIBRX BIOSCIENCES INC | 0.10% | — | $16 | 1.79M | new | $28.00M | New |
| 80 | TRVI TREVI THERAPEUTICS INC | 0.05% | — | $3 | 4.40M | new | $14.70M | New |
| 81 | PEPG PEPGEN INC | 0.05% | — | $9 | 1.48M | new | $12.67M | New |
| 82 | BNTX BIONTECH SE | 0.02% | — | $119 | 46K | new | $5.50M | New |
| 83 | — RALLYBIO CORP | 0.02% | — | $1 | 4.19M | new | $4.91M | New |
* Price = reported value ÷ shares at quarter end (13F does not disclose cost basis). Δ wt = this position's share of the reported portfolio versus the prior quarter. Options are shown separately when filed.
This quarter's moves
Filing detail
Period2024-09-30
Accepted14 Nov 2024 · 16:00 ET
Filing lag45 days
Form13F-HR
Information rows83
Quarters on file8
Portfolio value
Quarterly history · 8 filings
export all →
| Quarter | Period end | Reported value | Positions | Largest | New | Exited | Filed | Lag |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $35.08B | 90 | 6.3% | 35 | 22 | 14 Aug 2026 ET | 45 |
| Q1 2026 | 2026-03-31 | $35.75B | 77 | 5.4% | 20 | 19 | 15 May 2026 ET | 45 |
| Q4 2025 | 2025-12-31 | $37.68B | 76 | 4.1% | 21 | 23 | 17 Feb 2026 ET | 48 |
| Q3 2025 | 2025-09-30 | $38.50B | 78 | 4.2% | 15 | 20 | 14 Nov 2025 ET | 45 |
| Q2 2025 | 2025-06-30 | $34.59B | 83 | 4.3% | 20 | 28 | 14 Aug 2025 ET | 45 |
| Q1 2025 | 2025-03-31 | $31.48B | 91 | 4.7% | 27 | 22 | 15 May 2025 ET | 45 |
| Q4 2024 | 2024-12-31 | $30.90B | 86 | 5.8% | 22 | 19 | 14 Feb 2025 ET | 45 |
| Q3 2024 | 2024-09-30 | $27.44B | 83 | 5.6% | — | — | 14 Nov 2024 ET | 45 |
Track record · return since filing
leaderboard →
Paper return of each reported book
Since Q3 2024
+24.2%
S&P 500 +28.0%
Hit rate · latest book
37%
priced positions with positive return
Priced coverage
89%
of reported stock value
Quarter by quarter
| Quarter | Book | S&P 500 | Excess | Coverage | Best call |
|---|---|---|---|---|---|
| Q2 2026 | -1.9% | -4.1% | +2.3% | 89% | V +18.0% |
| Q1 2026 | +8.5% | +0.9% | +7.6% | 93% | V +32.2% |
| Q4 2025 | +8.2% | +9.6% | -1.4% | 91% | AMD +150.4% |
| Q3 2025 | +9.3% | +11.7% | -2.3% | 92% | AMD +106.1% |
| Q2 2025 | +12.5% | +16.7% | -4.2% | 92% | TSM +58.2% |
| Q1 2025 | +17.8% | +27.8% | -10.0% | 89% | BBIO +130.3% |
| Q4 2024 | +17.6% | +24.1% | -6.6% | 90% | BBIO +122.6% |
| Q3 2024 | +24.2% | +28.0% | -3.8% | 88% | BBIO +222.2% |
Copy-trade simulation
Hypothetical strategy
+27.8%
8 rebalances
S&P 500 same window
+28.0%
excess -0.1%
Simulation: at each filing date, buy the manager's ten largest reported common-stock positions in equal weight; hold until the next filing. Prices are split- and dividend-adjusted closes. It ignores the 45-day disclosure lag's cost to a real copycat beyond the filing-date entry, taxes, fees and liquidity. It is a reading aid, not a backtest of the manager's fund.